Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2016 /
Treating CNS metastases from breast cancer with a peptide/paclitaxel conjugate

7th - 11th Oct 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.10.16
Views: 2514

Prof Shou-Ching Tang - Augusta University Cancer Center, Augusta USA

Prof Tang speaks with ecancertv at ESMO 2016 about successes with ANG1005, a conjugate of paclitaxel with a peptide which can cross the blood brain barrier.

He describes the mechanism of the molecules infiltration and action within brain metastases of breast cancer, and considers further avenues for development through modified conjugates, and treatment of primary brain lesions.


Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation